558 filings
Page 9 of 28
8-K
py304th50zegin
14 Dec 21
Regulation FD Disclosure
4:30pm
8-K
c8rs794j4eamkblgo
8 Dec 21
Oncocyte and Burning Rock Complete Technology Transfer Part Two and Prepare for Scaled Distribution
8:05am
8-K
jcojpmgd3f4nucsqpy
9 Nov 21
Oncocyte Reports Third Quarter 2021 Financial Results and Provides Corporate Update
4:37pm
8-K
oqm65e
4 Nov 21
Oncocyte Announces the Clinical Launch of DetermaIO Immunotherapy Response Prediction Test
8:05am
8-K
d6oy5 7vu642q
27 Oct 21
U.S. patent builds upon prior EU patent protection enabling launch of Therasure Transplant Monitor LDT and FDA kits in both the U.S. and Europe
8:05am
4
zw27e8f ukv88
14 Oct 21
Oncocyte / Li Yu ownership change
4:05pm
3
sbped
14 Oct 21
Oncocyte / Gisela Paulsen ownership change
4:05pm
8-K
rzh9p8 mv3jdqi
7 Oct 21
Oncocyte Appoints Gisela A. Paulsen as Chief Operating Officer
8:05am
4
o0o4h s5f
24 Sep 21
Oncocyte / NEAL C BRADSHER ownership change
4:56pm
SC 13D/A
w2qgpf xj8zmsybgm
24 Sep 21
Oncocyte / BROADWOOD PARTNERS ownership change
4:40pm
8-K
702jfaov4j1cf3 eb
20 Sep 21
Oncocyte Announces Oral Presentation of New Data on Its DetermaIO™ Immunotherapy
11:40am
8-K
v8dgc3yd88ohf949r
10 Aug 21
Oncocyte Reports Second Quarter 2021 Financial Results and Provides Corporate Update
5:12pm
EFFECT
e3x83e27ww8 9yed
30 Jul 21
Notice of effectiveness
12:15am
424B3
vwt21mc
29 Jul 21
Prospectus supplement
4:01pm
CORRESP
tyodl9l tyxz
26 Jul 21
Correspondence with SEC
12:00am
UPLOAD
x5ydctz4
21 Jul 21
Letter from SEC
12:00am
8-K
blv 8zj2o
20 Jul 21
Changes in Registrant's Certifying Accountant
4:47pm